Phase II study of Efficacy and Safety of SJE-2079 in the Treatment for Diabetic Macular Edema.
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2012
At a glance
- Drugs Difluprednate (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 05 Jul 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 28 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 01 Jun 2011 New trial record